Novartis(NVS) - 2024 Q1 - Earnings Call Presentation

3 Novartis Q1 Results | April 23, 2024 Content Click below to navigate through the document Company overview Financial review Conclusions Appendix Novartis Q1 Results | April 23, 2024 4 U NOVARTIS | Reimagining Medicine Core1 operating income USD bn, % cc1 Q1 2023 Q1 2024 3.9 4.5 Core margin 38.4% (+340 bps) +22% Iptacopan FDA submission for IgAN Innovation milestones Fabhalta® positive CHMP opinion for PNH Sales USD million Growth vs. PY USD million Growth vs. PY cc Scemblix® 1L CML Ph3 readout Pluvicto® P ...